PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Nov-2019 Exclusive speaker interview released for SMi’s AI in Drug Discovery Conference 2020 SMi Group
18-Nov-2019 RhoVac Reports Interim Results on Immunological Response with RV001 RhoVac
18-Nov-2019 Vifor Pharma Appoints Lee Heeson as President International and Member of the Executive Committee Vifor Pharma
18-Nov-2019 Securecell Introduces Sephara, a Novel, Silicon-Based In-Situ Filtration Membrane B3C newswire
18-Nov-2019 MedGenome Selects Applied Biosystems Axiom Genotyping Platform to Enable Large-scale Genetic Studies in South Asian Populations MedGenome
18-Nov-2019 3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration 3SBio Inc.
18-Nov-2019 BioDuro chooses SciFinder-n from CAS to enhance research productivity and shorten cycle times for client success CAS
17-Nov-2019 Teens with Heart Disease Improve Exercise Capacity in Large Clinical Trial Children's Hospital of Philadelphia
17-Nov-2019 Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists Eli Lilly and Company
17-Nov-2019 Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF Novartis Pharmaceuticals Corporation
17-Nov-2019 Mezzion Pharma announces the presentation of the FUEL Trial data at the American Heart Association Meeting in Philadelphia Mezzion Pharma Co. Ltd.
17-Nov-2019 Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People Antimicrobial Resistance Summit Expert Group and the Antimicrobial Stewardship Working Group
17-Nov-2019 Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People Antimicrobial Resistance Summit Expert Group and the Antimicrobial Stewardship Working Group
16-Nov-2019 Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack Amgen
16-Nov-2019 Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack Amgen
16-Nov-2019 Carisma Therapeutics Announces Investor Conference Participation Carisma Therapeutics Inc.
16-Nov-2019 Carisma Therapeutics Announces Investor Conference Participation Carisma Therapeutics Inc.
15-Nov-2019 Statement from Sarah Yim, M.D., acting director of the Office of Therapeutic Biologics and Biosimilars in the FDA's Center for Drug Evaluation and Research, on FDA's continued progress facilitating competition in the biologic marketplace with approval of 25th biosimilar product U.S. Food and Drug Administration
15-Nov-2019 Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the American College of Emergency Physicians Portola Pharmaceuticals, Inc.®
15-Nov-2019 FDA clears first duodenoscope with disposable elevator piece, reducing the number of parts needing disinfection U.S. Food and Drug Administration